$CDRE

Cadre Holdings, Inc. (CDRE): Results of Operations and Financial Condition

Cadre Holdings, Inc. (CDRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cdre-20260805xex99d1.htm EX-99.1 Exhibit 99.1 Cadre Holdings Reports Second Quarter 2026 Financial Results ​ Grew Quarterly Net Sales 32% and Gross Profit 36% Year-Over-Year ​ Increased Quarterly Adjusted EBITDA and Expanded Adjusted EBITDA Margin Both Sequentially and

Original reporting
Published Aug 5, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CDRE
Bullish
high confidence
Mentioned
$CDRE
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CDREBullishHigh
01

Why it matters

The key tradable update is the raised full-year guidance, reinforced by record orders backlog and improved adjusted EBITDA margin, while cash and net debt moved higher.

02

Market read

Guidance raise plus record backlog and margin improvement are likely to drive near-term estimate revisions and sentiment, offset by weaker net income and higher leverage.

03

What to watch

Liquidity deteriorated (cash down, net debt up), so the market may scrutinize leverage and integration costs behind the guidance raise.

Relevance 9/10Novelty 9/10Timing: after-hours filing on Aug 5, 2026 with raised FY guidance

Background

Cadre filed an 8-K (Item 2.02) with Q2 2026 operating results, liquidity/capital allocation updates, and specific contract and acquisition updates.

Company-level read

Ticker impact

$CDREBullishHigh confidence
Context

Cadre reported Q2 2026 results and raised full-year guidance to net sales of $749 to $769 million and adjusted EBITDA of $139 to $144 million.

Expected impact

Likely positive near-term bias as guidance and backlog provide fresh fundamentals for earnings revisions.

Evidence & confidence

The filing is a primary disclosure (8-K with results and guidance) and includes multiple quantified improvements (sales, EBITDA, backlog) that typically drive estimate changes.

Market effects

Supports the narrative of resilient demand for mission-critical safety equipment tied to law enforcement and nuclear-related end markets.

Limited, company-specific impact; no broader regional macro signal in the text.

Modest, as the demand drivers cited are tied to US government and defense-related procurement.

Counterpoint

Net income declined year-over-year due to contingent consideration, compensation, and FX, which could temper enthusiasm despite EBITDA strength.

Key entities

  • Cadre Holdings, Inc.

    NYSE-listed safety equipment manufacturer reporting Q2 results and raising FY 2026 guidance.

  • Safariland

    Cadre subsidiary selected as the ballistic panel provider for Predictive Ballistics LLC’s Overt Armor Kit under an FBI IDIQ contract.

  • Predictive Ballistics LLC

    Provider of the Overt Armor Kit system that received a five-year FBI IDIQ contract.

  • Alien Gear Holsters

    Holster and gear manufacturer acquired by Cadre via a court-supervised bankruptcy auction.

Related articles

$CDREMedAI 8/10

Cadre Holdings’ (CDRE) Safariland Selected for FBI Ballistic Panel Contract

Cadre Holdings (NYSE:CDRE) said its subsidiary Safariland was selected to supply ballistic panels for an FBI armor contract. Safariland’s SX HP panels will be integrated into Predictive Ballistics’ Overt Armor Kit, after Predictive Ballistics won a five-year, $61 million IDIQ contract for the FBI and other DOJ agencies. The selection followed evaluation versus 11 competitors.

$VGMed

12 Best IPO Stocks with Huge Upside Potential

BNN Bloomberg interview (July 6) with Domini Impact Investments’ Maria Llerena said tech was weak into June but H1 was solid, with semiconductors and chips up nearly 90% by end-June. She cited AI-related CapEx concerns, estimating $800B in 2026, and noted a 50% chance of a Fed hike by year-end. The article then lists IPO stocks, including Venture Global (VG) and Cadre (CDRE).

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.